Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07707479

Cardiovascular Effects of Parathyroid Hormone Analogues in Chronic Hypoparathyroidism

Sponsor: National and Kapodistrian University of Athens

View on ClinicalTrials.gov

Summary

The goal of this study is to evaluate cardiovascular effects of long-acting parathyroid hormone (PTH) analogues in adults with chronic hypoparathyroidism. The main questions it aims to answer are: * Do patients with hypoparathyroidism have increased arterial stiffness and markers of subclinical cardiovascular injury compared to healthy individuals? * Does treatment with a long-acting PTH analogue improve vascular and cardiac function over time compared to conventional therapy? This is a multi-center study with two parts: a cross-sectional comparison and a 12-month prospective follow-up. Adults with chronic hypoparathyroidism and matched healthy controls will undergo clinical evaluation, vascular measurements, cardiac imaging, and blood tests. In the prospective part, patients that just started long-acting PTH analogue therapy based on their treating physicians choice will be followed for 12 months, with repeat assessments at baseline, 3 months, and 12 months to evaluate changes in cardiovascular markers.

Official title: Effect of Long-acting PTH Analogues on Markers of Subclinical Arterial and Myocardial Injury in Chronic Hypoparathyroidism..

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

210

Start Date

2026-04-01

Completion Date

2028-12-31

Last Updated

2026-07-16

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Arterial stiffness in the aorta by measurement of pulse wave velocity

Carotid-femoral pulse wave velocity (c-f PWV) is an established index of aortic stiffness and an independent predictor of worse cardiovascular prognosisIt is considered as the gold standard for assessing aortic stiffness non-invasively and is calculated from measurements of pulse transit time and the distance travelled between 2 recording sites with a validated non-invasive device (Complior, Artech Medical, France). Two different pulse waves are obtained at the same time transcutaneously with the patient in a supine position at 2 sites, at the right common carotid artery and the right femoral artery (i.e. 'carotid-femoral' PWV) by using pressure-sensitive transducers.

DIAGNOSTIC_TEST

Central blood pressures and reflected waves in the aorta

Non-invasive estimation of aortic pressure waveforms and reflected waves by pulse wave analysis (PWA) will be performed in the Angiology laboratory by the SphygmoCor System (AtCor Medical Pty Ltd, Sydney, Australia). The radial artery is gently and steadily compressed against the underlying bone, thus flattening it and equalizing circumferential pressures, allowing radial pressure waves to be recorded by a high fidelity micromanometer placed on the tip of a hand - held tonometer the size of a pen (Millar). Optimal recording is obtained if the wrist is bent outward and supported by using a small cushion or the operator's hand. The following indices are measured: 1. augmentation index (AI, percentage) normalized for the heart rate of 75 bpm, expressed as a percentage of the aortic pulse pressure, 2. central systolic and diastolic pressures (cBP), 3. time to the beginning of the reflected wave (in milliseconds) and 4. blood pressure amplification calculated as the ratio of peripheral

DIAGNOSTIC_TEST

Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques

B-mode ultrasound examination will also be performed, using a 14.0 MHz multi-frequency linear array probe attached to a high-resolution ultrasound machine (Vivid 7 Pro, GE Healthcare, USA). All scans are going to be performed by the same operator. Carotid intima-media thickness (ccIMT) will be measured at the distal 1.0 cm of the common carotid proximal to the bifurcation as previously described (23) . In each segment 3 measurements of the maximal IMT in the far wall will be averaged, after excluding plaque thickness. The average of the maximal IMT will be used in the analyses. Femoral IMT (fIMT) will be measured on each side, scanning a 1cm-long arterial segment proximal to the femoral bifurcation, defined as the common femoral artery segment and the average value of IMT of the far wall will be estimated. A cutoff value of \>0.9 mm for mean ccIMT or fIMT will be considered increased. Plaques to carotid and femoral arteries are defined as a focal structure that protrudes into the arteri

DIAGNOSTIC_TEST

Imaging of the sublingual microcirculation (GlycoCheck system)

The measurement procedure and the calculation of the sublingual microvascular parameters is performed as follows: the probe of a hand-held side-stream darkfield (SDF) videomicroscope (CapiScope HVCS, KK Technology, Honiton, UK) is placed on the sublingual mucosa of the subject, to obtain video recordings of the sublingual microvasculature. Subsequently, an analysis software (the GlycoCheck Measurement System Software Version 5.3.3) selects and analyses SDF images that are of sufficient quality (adequate focus, adequate contrast and limited movement) and automatically calculates the sublingual microcirculation parameters, such as vascular density (VD), red blood cell filling (RBCF), and perfused boundary region (PBR).

DIAGNOSTIC_TEST

Ankle-brachial index (ABI)

The primary non-invasive test for the diagnosis of lower extremity artery disease (LEAD) is the ABI. A cut-off value of \<0.9 will be used for the diagnosis of LEAD and as predictive index of atherosclerosis, associated with increased risk of cardiovascular morbidity and mortality. Also, a cut-off value of \>1.40 will be used as an index of stiffened arteries, also associated with increased mortality. For its measurement, a 10-12 cm sphygmomanometer cuff will be placed just above the ankle and a (handheld) Doppler instrument (5-10 MHz) will measure the pressure of the posterior and anterior tibial arteries of each foot. The highest ankle systolic pressure will be divided by the highest brachial systolic pressure, resulting in an ABI per leg.

DIAGNOSTIC_TEST

Fundoscopy

A set of colour and black-and-white fundus images photograph per eye will be taken by well-trained ophthalmic photographers: macula-centered images using the handheld Optomed Aurora fundus cameras without pupil dilation. The images obtained with the handheld fundus camera had a field of view of 50° and 5 mega-pixel resolution

DIAGNOSTIC_TEST

Cardiac Ultrasonography Study

Participants will undergo a baseline echocardiographic examination. Standard protocol will be used and standard measurements from 2-D and Doppler echocardiography will be made. LV end-diastolic and end-systolic volumes, as well as ejection fraction, will be derived from the apical 4- and 2-chamber views using the biplane Simpson's rule. Left ventricular mass will be calculated according to Devereux's formula. Doppler examination will include interrogation of mitral inflow, and early (E) and late (A) peak diastolic velocities and deceleration time will be measured. Tissue Doppler analysis will include pulse wave interrogation of the medial and lateral mitral annulus, peak diastolic early E΄ annular velocities will be obtained and the mean value and E/E' will be calculated. In addition, Speckle-tracking analysis will be applied to estimate LV rotational mechanics, and longitudinal strain parameters. Parasternal short-axis views at the level of the mitral valve and apex, and standard apic

DIAGNOSTIC_TEST

Local shear stress in brachial and carotid artery

In order to calculate local shear stress in brachial and carotid artery, measurements of mean flow velocity in the lumen of these arteries will be needed. These measurements will be obtained, while performing carotid ultrasonography and FMD in brachial artery, as previously described. In detail, the form to calculate shear stress is: shear stress (in dyn/cm2 ) = 8×μ× mean flow velocity/resting diameter, where μ is the viscosity of blood which was assumed to be 0.035 dyne s/cm2

DIAGNOSTIC_TEST

Peripheral and aortic office and ambulatory blood pressure

The peripheral and aortic office blood pressure will be assessed using specialized equipment (certified blood pressure monitor). 24-hour Ambulatory Blood pressure monitoring for measurement of 24 hour peripheral and aortic

DIAGNOSTIC_TEST

Circulating levels of myocardial biomarkers

Fasting venous blood samples will be collected for evaluation of myocardial biomarkers (hs-troponin I, NT-proBNP). Additional samples will be obtained for isolation of PBMCs.

DIAGNOSTIC_TEST

Evaluation of Calcium metabolism

Fasting venous blood samples will be collected for evaluation of calcium metabolism (PTH, calcium, albumin, magnesium, phosphate, 25-hydroxyvitamin D) .

Locations (2)

Alexandra General Hospital of Athens

Athens, Greece

Medical School, National and Kapodistrian University of Athens, LAIKO General Hospital of Athens

Athens, Greece